Policy / Pricing US pharma tariffs of up to 100% finalised by Trump PharmaphorumTrump signs his pharma tariffs executive order, which won't affect most large pharma groups but could deal a hefty blow to smaller companies.Policy / PricingRead full story pharminent April 3, 2026 (Last updated: April 3, 2026) Pharmaphorum Trump signs his pharma tariffs executive order, which won’t affect most large pharma groups but could deal a hefty blow to smaller companies. Policy / PricingRead full story Post navigation Previous: Trump Hits Drugmakers With 100% Tariff but Carve-outs Soften the BlowNext: BioNTech Starts Shuttering Singapore mRNA Manufacturing Site Amid Pipeline Pivot Related Stories Policy / Pricing Mid-cap biotechs join Trump’s latest round of drug pricing deals pharminent September 1, 2026 Policy / Pricing MFN sparks defiance from Europe’s larger nations, uncertainty among smaller ones pharminent August 27, 2026 Policy / Pricing MFN affecting Swiss medicines access, says Interpharma pharminent August 13, 2026